China aims to boost drug safety; Kansas State system scrubs wastewater;

> Chinese officials have approved a plan to intensify monitoring for pharmaceutical groups to boost drug safety. Story

> Bioprocessing engineers at Kansas State University's Advanced Manufacturing Institute have won a patent for a system that removes phosphorus from wastewater and addresses environmental regulations. Release

> AstraZeneca ($AZN) said it will buy Chinese generic antibiotic injectables maker Guandong Beikang Pharmaceutical. News

> The National Crime Prevention Council highlights medications for chronic diseases as among those consumers should scrutinize for signs of counterfeiting.  Story

> A guide to wholesaling medicinal products for human use in Ireland is available from the Irish Medicines Board. Guidance | Summary by Rx-360

> Virginia's Fairfax County police have raided 13 businesses, likely scoring the largest seizure of prescription drugs in county history. Article

> UPS ($UPS) has agreed to by Italy's Pieffe Group, a family-owned provider of pharma logistics services. Release

> Indian generics API maker Nectar Lifesciences has been given a thumbs-up for its cephalasporin formulations manufacturing facility in Himachal Pradesh. Story

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.